The Medication Adherence Rating Scale (MARS) is one of the most widely used measurements of adherence in schizophrenia (SZ), but there is no available data regarding its psychometric properties in . The recently developed Osteoporosis-Specific Morisky Medication Adherence Scale (OS-MMAS-8) is a modified version of the 8-item Morisky Medication Adherence Scale (MMAS-8), which was designed to capture barriers to and behaviors associated with medication adherence. PDF Self-reported Morisky 8 item medication adherence scale to Donald E. Morisky - Google Scholar The Morisky scale is a validated scale designed to estimate the risk of medication non-adherence. The 8-item Morisky Medication Adherence Scale: Validation OBJECTIVE: To translate and examine the psychometric properties of the Portuguese version of the structured self-report eight-item Morisky Medication Adherence Scale among patients with hypertension. Lawyers representing the purported owner of the Morisky Medication Adherence Scale (both MMAS-4 and MMAS-8), and one of its authors, Dr. Donald Morisky, have threatened universities and researchers (including here at Penn) with copyright infringement and breach of contract lawsuits, and pushed for retraction of publications, when a researcher has used either MMAS-4 or MMAS-8 as part of . Objective: To validate a Greek version of the structured self-reported 8-item Morisky Medication Adherence Scale (MMAS-8) and determine its psychometric properties in patients with chronic illnesses. Objective A new 8-item self-reported Morisky Medication Adherence Scale (MMAS) has been developed and has shown better psychometric properties than the original 4-item Morisky scale. Medication adherence among type 2 diabetes mellitus patients was assessed by a questionnaire developed using Morisky Medication Adherence Scale, Hill-Bone Compliance to High Blood Pressure Therapy . Morisky Medication Adherence Scale (MMAS) Medication Adherence Report Scale (MARS) Medication Assessment Questionnaire (MAQ) Brief Medication Questionnaire (BMQ) Simple 1-item VAS [note: measures can be adapted to specific conditions/treatment] 0% means you have taken none of the It has been cited in over 70 articles since its publication in 1986. A tool is lacking to assess adherence in gout that is standardized, allows real-time feedback, and is easy to understand.Objective: We set out to evaluate the utility of the 8-item Morisky Medication Adherence Scale (MMAS-8) in monitoring medication adherence in a multiethnic Asian gout cohort on urate-lowering therapy (ULT).Methods: This . This study aimed to validate the 8-item Morisky Medication Adherence Scale (MMAS) in patients taking warfarin in Singapore. The range of the scale is from 0 to 8 with 0 being low adherence and 8 being high adherence. Background: The number of patients with type 2 diabetes (T2D) is increasing. The Morisky Medication Adherence Scale, otherwise known as the Morisky Scale (MMAS-8), has proved to be a valuable resource to address adherence concerns, such as forgetting to take medications or discontinuing medications without guidance. Objective We studied the concordance of a patient self-report method, Morisky eight-item medication adherence scale (MMAS)), with the pill count method in measuring . The outcome measure was the Morisky Medication Adherence Scale (MMAS-8). Reliability was assessed by a test-retest method. It is a self-reported questionnaire, designed to help physicians to understand their patient's beliefs and concerns, how well they are adhering, and provide feedback and support. Scores are based on patient responses to and called the Morisky Medication Adherence Scale (MMAS) [19]. 24x7x365 Home Monitoring Video Direct Observation Therapy Medication treatment is of great importance to stabilize blood glucose. The sample consisted of 100 patients with various . The Morisky Medication Adherence Scale (MMAS-8) remains one of the most widely used mechanisms to assess patient adherence. Methods: A cross-sectional survey was conducted in a small public hospital and a public health care centre, in a rural town in western Greece. In Spain, no studies to date have analyzed the psychometric properties of the scale in psychiatric care. Medication Adherence Antihypertensive medication adherence was ascertained using the self-report 8-item Morisky Medication Adherence Scale (MMAS-8). Results From 1114 patients, 725 (65.1%) had good adherence to antihypertensive agents. This measure was designed to facilitate the identification of barriers to and behaviors associated with adherence to chronic medications and has been Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8) Xi Tan Isha Patel Jongwha Chang Keywords: medication adherence, Morisky Scale Abstract. Scores on the MMAS-8 range from 0 to 8. The three parts of an eight-item self-reported scale has been developed by the data collection sheet were translated together according to Morisky et al. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The tendency in responding to questions about their regimen adherence is . 19 , 20 , 21 The cut-off point of 3 and above was used to define non-adherence in this study. Background It is imperative that non-compliance with statins be identified and addressed to maximize their clinical benefits. The 8-item Morisky Medication Adherence Scale (MMAS-8) is a structured, self-reported 8-item questionnaire, 9 which has been validated in several chronic diseases. Because of the wide use of the scale as a medication adherence measurement tool, we were interested in translating the MMAS and documenting some of its psychometric properties in Malaysian people with type . stop animation stop. Binary logistic regression analysis was conducted. Recently, an eight-item self-reported scale has been developed by Morisky et al. The Morisky scale is a validated scale designed to estimate the risk of medication non-adherence. Compared to original Morisky scale, it has the following Scores are based on patient responses to four, Yes or No questions. The eight-item Morisky Medication Adherence Scale (MMAS-8) is frequently used for measuring drug adherence, yet the association between MMAS-8 score and glycaemic control among diabetes patients has not been addressed. The Morisky scale is a validated scale designed to estimate the risk of medication non-adherence. I wanted to use validated scale for measuring medication adherence in my participants having type 2 diabetes.Please I wanted to know which is the best and easy in getting permission.I am thinking . The instrument can be used initially to identify patients with adherence problems and can also be used to monitor adherence over the course of the treatment. None of the available methods for measuring medication adherence is currently regarded as a universal consensus gold standard. The Morisky Widget assessment results targets and tailors Interventions to improve medication adherence. A self-reporting questionnaire is the most convenient and cheapest way to assess medication adherence. Its translation and testing on languages in addition to English would be very useful in research and in practice. Therefore, we aimed to validate the MMAS-8 for detecting nonadherent patients with chronic pain. Link to Instrument Instrument Details Acronym MMAS-8 Cost Not Free Cost Description Users must contact the author for pricing and licensing Diagnosis/Conditions Arthritis + Joint Conditions Cardiac Dysfunction Diabetes The reliability and validity of the MMAS-8 in patients with chronic pain were unclear. Only Morisky's Medication Adherence Scale (MMAS) had been validated in a Saudi population (AlHewiti, 2014; Shilbayeh et al., 2018). MORISKY ET AL. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Objective: To validate a Greek version of the structured self-reported 8-item Morisky Medication Adherence Scale (MMAS-8) and determine its psychometric properties in patients with chronic illnesses. Adherence with oral hypoglycaemic agent is crucial to achieve optimal glycaemic control. MMAS means Morisky Medication Adherence Scale. Following publication of the original article , some errors were identified in relation to the Morisky Medication Adherence Scale (MMAS-8). We train and certify enterprise health care providers through classes that encourage patient-centered educational counseling, thus increasing their medicine-taking behavior. Methods: A cross-sectional survey was conducted in a small public hospital and a public health care centre, in a rural town in western Greece. The Morisky Medication Adherence Scale (MMAS-8) remains one of the most widely used mechanisms to assess patient adherence. A Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients M Krousel-Wood, S Thomas, P Muntner, D Morisky Current opinion in cardiology 19 (4), 357-362 , 2004 Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8) Xi Tan Isha Patel Jongwha Chang Keywords: medication adherence, Morisky Scale Abstract. The measure is more than just a number, it allows the health professional to know why the patient is not taking their . Medication Adherence Rating Scale; MARS (Thompson et al, 2000) Thompson et al (2000) identified several deficiencies in the DAI as a measure of adherence and proposed a new inventory, the MARS scale, that incorporates features of both the DAI and the MAQ (Morisky et al, 1986) but which they claimed to have greater Morisky Medication Adherence Scale (MMAS-8) [22]. the Medication Adherence Questionnaire (MAQ; also known as Morisky 4), the Self-efficacy for Appropriate Medication Use Scale (SEAMS), the Brief Medication Questionnaire (BMQ), the Hill-Bone Compliance Scale, and the Medication Adherence Rating Scale (MARS).7-14 Below is a summary of the positive The MAQ (also known as the 4-item Morisky Medication Adherence Scale [MMAS-4] and Morisky Scale) is the most common adherence scale. The Medication Adherence Questionnaire (MAQ), also known as the 4-item Morisky Medication Adherence Scale (MMAS-4) and Morisky Scale, 2 is the most common adherence scale, and is short, simple to use, and validated across many different disease areas. MMAS is a shorter form of Morisky Medication Adherence Scale. The Morisky Medication Adherence Scale (MMAS-8) is one of the most commonly used self-reporting methods [8, 9]. The questionnaire assessed current hemoglobin A 1c (HbA 1c) levels, demographic and disease characteristics, and treatment adherence with the 8-item version of the Morisky Medication Adherence Scale (MMAS-8). Scores are based on patient responses to four, Yes or No questions. A score of 4 means high adherence, 2-3 means moderate adherence, and 0-1 means low adherence. Good adherence was defined as MMAS scores greater than 6 points (out of a total score of 8 points). The 8-item Morisky Medication Adherence Scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patients. Erratum. Medication Adherence At the Medication Adherence Research Institute, we focus on identifying more effective ways to get people to adopt healthier behaviors. Patient self-reporting methods are convenient to apply in clinical practice but need to be validated. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients . . - The legend related to Table 1 should read: Morisky Medication Adherence Score < 6 was defined as low comorbidity medication adherence.